Medically reviewed by Jay N. Yepuri, MD Biliary colic is abdominal pain that develops due to a blockage in the bile ducts, ...

Biliary tract disease describes any disease that affects the biliary tract the gall bladder, bile ducts and accompanying structures. Examples include primary sclerosing cholangitis, secondary ...

Biliary dyskinesia is a functional disorder that occurs when your gallbladder (a small pear-shaped organ that stores and processes) can't contract and release bile effectively. Bile is important ...

Primary biliary cirrhosis (PBC) is a chronic, cholestatic liver disease characterized by progressive destruction of intrahepatic bile ducts, resulting in chronic cholestasis, portal inflammation ...

COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies designed ...

A primary biliary cholangitis (PBC) diagnosis can be life-changing. For many, it’s an emotional journey filled with questions, uncertainties and a need to redefine what life looks like with a ...

Focal obliteration of bile ducts, secondary to cholangitis, was frequent, and may have been the cause of extrahepatic biliary atresia in two cases. The nature of the association between this ...

A. W. (M. G. H. 728055), a 68-year-old domestic worker, was in excellent health until 1 month before admission to the hospital. At that time she became jaundiced; the stools became acholic, and ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

TAS-0728 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Biliary Tumor. According to GlobalData, Phase II drugs for Biliary Tumor does not have sufficient ...

The FDA has granted Cour Pharmaceuticals orphan drug designation for CNP-104, a biodegradable nanoparticle in development for ...